当前位置:首页 - 行情中心 - 万泰生物(603392) - 财务分析 - 现金流量表

万泰生物

(603392)

  

流通市值:605.11亿  总市值:605.11亿
流通股本:12.65亿   总股本:12.65亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,803,955,458.741,090,752,777.2574,456,759.023,318,765,321.94
  收到的税费返还17,053.733,068.483,068.4821,923,520.79
  收到其他与经营活动有关的现金117,080,445.6878,865,735.8254,063,460.64329,904,788.73
  经营活动现金流入小计1,921,052,958.151,169,621,581.5628,523,288.143,670,593,631.46
  购买商品、接受劳务支付的现金419,100,138.2263,620,598.96176,433,601.75622,620,315.28
  支付给职工以及为职工支付的现金798,829,410.92574,836,717.51344,074,013.121,032,462,819.19
  支付的各项税费107,439,584.9280,202,387.8841,000,836.75136,080,057.58
  支付其他与经营活动有关的现金588,399,269.44317,515,282.71152,987,767.181,524,348,792.72
  经营活动现金流出小计1,913,768,403.481,236,174,987.06714,496,218.83,315,511,984.77
  经营活动产生的现金流量净额7,284,554.67-66,553,405.56-85,972,930.66355,081,646.69
二、投资活动产生的现金流量:
  收回投资收到的现金3,984,425,204.452,218,505,7601,678,259,0805,932,026,208.33
  取得投资收益收到的现金102,983,184.4349,474,203.317,742,951.9143,174,782.76
  处置固定资产、无形资产和其他长期资产收回的现金净额48,990.8544,768.8543,756.4616,055,582.55
  收到的其他与投资活动有关的现金302,022.04--25,400,359.52
  投资活动现金流入小计4,087,759,401.772,268,024,732.151,696,045,788.366,116,656,933.16
  购建固定资产、无形资产和其他长期资产支付的现金557,471,858.41432,022,484.44155,283,188.38887,349,661.68
  投资支付的现金923,443.68--6,726,681,360
  支付其他与投资活动有关的现金3,606,361,2002,335,361,2001,947,000,0005,985,111.68
  投资活动现金流出小计4,164,756,502.092,767,383,684.442,102,283,188.387,620,016,133.36
  投资活动产生的现金流量净额-76,997,100.32-499,358,952.29-406,237,400.02-1,503,359,200.2
三、筹资活动产生的现金流量:
  吸收投资收到的现金---78,213,621.53
  取得借款收到的现金249,073,800.99119,383,754.94-231,236,626.55
  收到其他与筹资活动有关的现金2,851,954.561,214,782.56812,082.56-
  筹资活动现金流入小计251,925,755.55120,598,537.5812,082.56309,450,248.08
  偿还债务支付的现金231,825,639.41160,733,219.517,086,760252,388,246.49
  分配股利、利润或偿付利息支付的现金1,314,939.151,082,833.08581,430.98410,941,371.27
  其中:子公司支付给少数股东的股利、利润---760,500
  支付其他与筹资活动有关的现金7,601,461.635,565,057.081,895,201.35258,864,052.23
  筹资活动现金流出小计240,742,040.19167,381,109.6619,563,392.33922,193,669.99
  筹资活动产生的现金流量净额11,183,715.36-46,782,572.16-18,751,309.77-612,743,421.91
四、汇率变动对现金及现金等价物的影响-4,670,237.65-891,741.35-233,920.664,384,996.85
五、现金及现金等价物净增加额-63,199,067.94-613,586,671.36-511,195,561.11-1,756,635,978.57
  加:期初现金及现金等价物余额2,027,005,826.52,027,005,826.52,027,005,826.53,783,641,805.07
  期末现金及现金等价物余额1,963,806,758.561,413,419,155.141,515,810,265.392,027,005,826.5
补充资料:
  净利润--145,492,229.78-109,094,522.37
  资产减值准备-23,426,159.84-103,626,312.79
  固定资产和投资性房地产折旧-126,633,472.93-229,127,550.66
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-126,633,472.93-229,127,550.66
  无形资产摊销-19,133,905.37-31,581,210.67
  长期待摊费用摊销-10,394,548.6-17,590,376.96
  处置固定资产、无形资产和其他长期资产的损失-146,644.6--7,923,472.52
  固定资产报废损失-1,117,276.03-533,053.64
  公允价值变动损失--17,591,273.78--36,707,335.76
  财务费用-3,408,049.43--25,056,750.39
  投资损失--44,357,628.65--109,636,079.11
  递延所得税--8,191,106.5--85,378,260.2
  其中:递延所得税资产减少--8,191,106.5--85,378,260.2
  存货的减少--110,937,022.61--58,184,275.09
  经营性应收项目的减少-140,006,200.46-940,331,796.27
  经营性应付项目的增加--142,749,151.44--805,750,311.64
  其他----5,280,060.19
  不涉及现金收支的投资和筹资活动金额其他项目---132,741,337.08
  现金的期末余额-1,413,419,155.14-2,027,005,826.5
  减:现金的期初余额-2,027,005,826.5-3,783,641,805.07
  现金及现金等价物的净增加额--613,586,671.36--1,756,635,978.57
公告日期2025-10-302025-08-212025-04-252025-04-12
审计意见(境内)标准无保留意见
TOP↑